MGTA

Magenta Therapeutics Inc

About MGTA

Magenta Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is developing medicines designed to bring the curative power of stem cell transplants to more patients with blood cancers, genetic diseases and autoimmune diseases. Its drug development pipeline includes multiple product candidates designed to improve stem cell transplants. Its lead clinical program is designed to mobilize and collect sufficient functional stem cells for use in stem cell transplantation, a process known as mobilization. It is also developing product candidates that are designed to deplete targeted cells in the bone marrow to make space for the bone marrow to receive newly transplanted stem cells, a process known as conditioning. The Company's pipeline of stem cell transplant product candidates consists of MGTA-145, MGTA-117, C300, C100, G100, MGTA-456 and E478. It is developing product candidates to be used individually or, in some cases, in combination with each other.

Buy US stocks in Australia starting with MGTA. Open an account and start investing today!

Market Capitalisation

$26.65M

Price-earnings ratio

Dividend yield

0.00%

Volume

927.42K

High today

$0.48

Low today

$0.43

Open price

$0.44

52-week high

$3.62

52-week low

$0.32

MGTA FAQs

How much is one share of Magenta Therapeutics Inc?

One share of Magenta Therapeutics Inc is valued at $0.46.

What is the ticker symbol for Magenta Therapeutics Inc?

The ticker symbol for Magenta Therapeutics Inc is MGTA.

How do I buy MGTA shares in Australia?

To buy MGTA stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in MGTA

What is the market capitalisation of Magenta Therapeutics Inc MGTA?

As of 27/01/2023 Magenta Therapeutics Inc has a market cap of $27M.

What is the 52-week high for Magenta Therapeutics Inc stock?

The Magenta Therapeutics Inc 52-week high stock price is $3.62.

What is the 52-week low for Magenta Therapeutics Inc stock?

The Magenta Therapeutics Inc 52-week low stock price is $0.32.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.